×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| FORTIS HEALTHCARE LTD. | 4730.4 | 518.8 | 4330.3 | 0.69 | 71,559 | 77.8 |
| ABBOTT INDIA LTD. | NA | NA | NA | NA | 66822 | 46.0 |
| Alkem Laboratories Limited | 24887.5 | 6561.6 | 23721.7 | 52.04 | 63764 | 28.0 |
Fortis Healthcare Ltd, with Security Code 532843, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 277.5 | 289.1 | 294.1 | 290.8 | 307.5 | 333.4 | 357.2 | 366.9 | 388.5 | 433.0 |
| Expenses | 249.9 | 253.9 | 254.5 | 242.0 | 238.2 | 275.5 | 297.3 | 300.1 | 317.5 | 344.9 |
| Operating Profit | 27.5 | 35.2 | 39.6 | 48.7 | 69.3 | 57.9 | 59.9 | 66.8 | 71.0 | 88.1 |
| OPM % | 9.93% | 12.16% | 13.47% | 16.76% | 22.54% | 17.38% | 16.76% | 18.2% | 18.28% | 20.35% |
| Other Income | 30.1 | 30.6 | 109.8 | 31.7 | 64.6 | 35.4 | 35.9 | 39.5 | -27.4 | 56.9 |
| Interest | 24.8 | 23.3 | 20.8 | 19.4 | 18.4 | 16.8 | 16.3 | 26.5 | 51.9 | 51.9 |
| Depreciation | 29.4 | 24.8 | 25.1 | 25.3 | 25.9 | 26.0 | 27.4 | 29.0 | 30.5 | 30.2 |
| Profit before tax | 3.5 | 17.7 | 42.0 | 35.8 | 57.5 | 50.5 | 120.3 | 45.3 | 13.6 | 46.1 |
| Tax % | -40.5% | -27.1% | -7.9% | -35.9% | -23.7% | 46.9% | -23.8% | -22.1% | 0% | 17.6% |
| Net Profit | 2.1 | 12.9 | 95.3 | 22.9 | 68.3 | 26.8 | 39.6 | 39.6 | -42.2 | 51.9 |
| EPS in Rs | 0.03 | 0.17 | 1.26 | 0.3 | 0.9 | 0.36 | 0.52 | 0.52 | 0 | 0.69 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,559.9 | 1,642.7 | 1,657.4 | 1,770.0 | 1,679.7 | 1,785.9 | 1,858.9 | 1,988.4 | 1,928.3 | 2,007.2 |
| Expenses | 1,283.4 | 1,371.8 | 1,385.6 | 1,439.8 | 1,395.7 | 1,404.8 | 1,516.4 | 1,553.6 | 1,553.1 | 1,571.7 |
| Operating Profit | 276.4 | 270.9 | 271.8 | 330.2 | 284.0 | 381.0 | 342.5 | 434.8 | 375.1 | 435.5 |
| OPM % | 17.72% | 16.49% | 16.4% | 18.65% | 16.91% | 21.34% | 18.43% | 21.87% | 19.45% | 21.7% |
| Other Income | 23.2 | 24.3 | 9.6 | 17.2 | 14.5 | 12.9 | 13.2 | -46.5 | 44.7 | -33.8 |
| Interest | 33.4 | 31.7 | 31.5 | 31.8 | 33.0 | 34.7 | 35.3 | 36.4 | 45.2 | 67.6 |
| Depreciation | 82.8 | 81.8 | 79.2 | 84.1 | 86.9 | 92.2 | 91.0 | 95.1 | 97.3 | 102.2 |
| Profit before tax | 172.0 | 171.2 | 169.3 | 227.7 | 170.9 | 263.9 | 229.3 | 316.6 | 253.5 | 285.5 |
| Tax % | -24% | -24.8% | -27.3% | -21.1% | -27.4% | -25.6% | -24.4% | 26.5% | 9% | -20.9% |
| Net Profit | 142.1 | 138.3 | 124.0 | 183.9 | 134.2 | 203.1 | 174.0 | 193.1 | 254.3 | 188.0 |
| EPS in Rs | 1.72 | 1.76 | 1.48 | 2.3 | 1.78 | 2.37 | 2.2 | 2.34 | 3.28 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 16% |
| 3 Years: | 19% |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | -27% |
| 3 Years: | 158% |
| TTM: | 3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 45% |
| 3 Years: | 43% |
| 1 Year: | 53% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 11% |
| 3 Years: | 11% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 70% |
| 3 Years: | 31% |
| TTM: | 44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 45% |
| 3 Years: | 43% |
| 1 Year: | 53% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|